The article entitled "Biosimilars in the EU: Nonclinical and Early Clinical Development” prepared by Voisin Consulting Life Sciences is now available in the November 2010 issue of Drug Information Journal. It provides an overview of the current regulatory framework, applicable guidelines and key stakeholders in the EU regulatory environment for Biosimilars.


